CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 145 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $98,000 | -38.0% | 14,000 | -26.3% | 0.01% | -33.3% |
Q1 2022 | $158,000 | +22.5% | 19,000 | 0.0% | 0.02% | +25.0% |
Q4 2021 | $129,000 | +27.7% | 19,000 | 0.0% | 0.01% | +20.0% |
Q3 2021 | $101,000 | -7.3% | 19,000 | 0.0% | 0.01% | -9.1% |
Q2 2021 | $109,000 | +23.9% | 19,000 | 0.0% | 0.01% | +22.2% |
Q1 2021 | $88,000 | +39.7% | 19,000 | 0.0% | 0.01% | +28.6% |
Q4 2020 | $63,000 | +12.5% | 19,000 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $56,000 | -36.4% | 19,000 | 0.0% | 0.01% | -46.2% |
Q2 2020 | $88,000 | +20.5% | 19,000 | 0.0% | 0.01% | +8.3% |
Q1 2020 | $73,000 | +2.8% | 19,000 | 0.0% | 0.01% | +33.3% |
Q4 2019 | $71,000 | -29.7% | 19,000 | 0.0% | 0.01% | -30.8% |
Q3 2019 | $101,000 | +38.4% | 19,000 | 0.0% | 0.01% | +30.0% |
Q2 2019 | $73,000 | -24.7% | 19,000 | 0.0% | 0.01% | -28.6% |
Q1 2019 | $97,000 | +169.4% | 19,000 | 0.0% | 0.01% | +133.3% |
Q4 2018 | $36,000 | -50.0% | 19,000 | 0.0% | 0.01% | -33.3% |
Q3 2018 | $72,000 | +22.0% | 19,000 | 0.0% | 0.01% | +125.0% |
Q2 2018 | $59,000 | +31.1% | 19,000 | 0.0% | 0.00% | -42.9% |
Q1 2018 | $45,000 | -39.2% | 19,000 | 0.0% | 0.01% | -36.4% |
Q4 2017 | $74,000 | +54.2% | 19,000 | 0.0% | 0.01% | +57.1% |
Q3 2017 | $48,000 | -7.7% | 19,000 | 0.0% | 0.01% | -12.5% |
Q2 2017 | $52,000 | +40.5% | 19,000 | 0.0% | 0.01% | +33.3% |
Q1 2017 | $37,000 | +85.0% | 19,000 | 0.0% | 0.01% | +100.0% |
Q4 2016 | $20,000 | -4.8% | 19,000 | 0.0% | 0.00% | -25.0% |
Q3 2016 | $21,000 | +61.5% | 19,000 | 0.0% | 0.00% | +100.0% |
Q2 2016 | $13,000 | – | 19,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,378,584 | $3,116,000 | 2.30% |
TANAKA CAPITAL MANAGEMENT INC | 147,993 | $298,000 | 0.90% |
SOPHROSYNE CAPITAL LLC | 282,500 | $638,000 | 0.56% |
Ghost Tree Capital, LLC | 200,000 | $452,000 | 0.27% |
Orbimed Advisors | 1,895,000 | $4,283,000 | 0.05% |
Financial Architects, Inc | 30,000 | $68,000 | 0.04% |
Cowen Prime Services LLC | 43,550 | $98,000 | 0.04% |
Rotella Capital Management, Inc. | 12,300 | $28,000 | 0.03% |
FEDERATED HERMES, INC. | 3,267,000 | $7,384,000 | 0.02% |
Baker Brothers Advisors | 569,853 | $1,288,000 | 0.02% |